Field Trip Health Ltd. ( FTRP) Stock. Should you Buy or Sell? $ 0.84
0.01 (0.80 %)
Field Trip Health Ltd. Analysis
Updated on 10-09-2022| Symbol | FTRP |
| Price | $0.84 |
| Beta | 0.000 |
| Volume Avg. | $61.09 thousand |
| Market Cap | $9.82 M |
| 52 Week Range | $0.8141 - $32.05 |
Field Trip Health Ltd. opened the day at $0.84 which is +'0.80 % on yesterday's close. Field Trip Health Ltd. has a 52 week high of $32.05 and 52 week low of $0.8141, which is a difference of $31.2359. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $9.82 M and total net profit is $4860129 which means the company is trading at 2.02 times profit to market capitalization. Theoretically, if you were to buy Field Trip Health Ltd. for $9.82 M, it would take 15 years to get your money back. Field Trip Health Ltd. are in the Medical Care Facilities space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
Field Trip Health Ltd. Stock Forecast - Is Field Trip Health Ltd. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Sell | |
| ROA Score | Sell | |
| DE Score | Buy | |
| PE Score | Sell | |
| PB Score | Strong Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | -0.222 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | -13.929 |
Valuing Field Trip Health Ltd.
| Price Book Value Ratio | 0.231 | Price To Book Ratio | 0.231 |
| Price To Sales Ratio | 3.091 | Price Earnings Ratio | -0.222 |
How liquid is Field Trip Health Ltd.
| Current Ratio | 2.534 |
| Quick Ratio | 1.387 |
Debt
| Debt Ratio | 0.394 | Debt Equity Ratio | 0.651 |
| Long Term Debt To Capitalization | 0.000 | Total Debt To Capitalization | 0.000 |
Latest news about Field Trip Health Ltd.
Field Trip Health Ltd. (NASDAQ:FTRP ) Q1 2023 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Kathleen Heaney - KCSA Strategic Communications Ronan Levy - Chairman and Chief Executive Officer of Field Trip Health & Wellness Joseph Del Moral - Chairman and Chief Executive Officer Donna Wong - Chief Financial Officer Nathan Bryson - Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Nicolaus Patrick Trucchio - H.C.
Field Trip Health Ltd. (NASDAQ:FTRP ) Q4 2022 Earnings Conference Call June 30, 2022 8:30 AM ET Company Participants Kathleen Heaney - Investor Relations Joseph Del Moral - Co-Founder and Chief Executive Officer Ronan Levy - Co-Founder and Executive Chairman Donna Wong - Chief Financial Officer Paula Hewitt - Vice President and General Counsel Nathan Bryson – Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Patrick Trucchio - H.C.
The three major U.S. equity indexes closed lower Monday, with the Nasdaq dipping by 0.72%, the S&P 500 sliding 0.3% and the Dow Jones industrials closing down 0.2%.
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside chat at the H.C. Wainwright 1st Annual Mental Healthcare Conference taking place June 27, 2022.
- Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice - Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice
About Field Trip Health Ltd.
Description :
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
